Medical University of South Carolina (MUSC) researchers report in Molecular Cancer Research that they have identified specific sugar structures that correlate to specific subtypes of hepatocellular carcinoma (HCC), the most ...
Sep 21, 2021
0
47
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men.
Jul 7, 2021
0
9
A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery. The device is shown to accurately identify tissues and surgical margins directly in patients and differentiate ...
Jul 6, 2021
0
17
Lung tumors are divided into various types, such as small cell lung cancer, adenocarcinoma and squamous cell carcinoma. Many rare tumor types and sub-types also exist. This diversity hampers reliable rapid diagnostic methods ...
Jun 28, 2021
0
19
U.S. regulators have approved the first medicine for patients with the most common type of lung cancer whose tumors have a genetic mutation long considered untreatable with drugs.
May 28, 2021
0
2
Heart disease and cancer are the leading causes of death in the United States, and it's increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic ...
May 20, 2021
0
20
Some of the world's greatest innovations, such as Leonardo da Vinci's flying machine, owe their strength and elegance to natural design. Researchers from the University of Illinois Urbana-Champaign have returned their gaze ...
May 5, 2021
0
36
Endocrine disruptors (EDs) are hormone-like substances that can have undesirable effects on health. For example, chemicals can increase the risk of breast cancer if they act in a manner similar to the female sex hormone estrogen. ...
Feb 26, 2021
0
18
Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research. Glioblastoma is an aggressive form of primary brain tumor—fewer ...
Feb 12, 2021
0
35
A University of Arizona Health Sciences study has estimated total lifetime costs at $736 million for the 10,359 valley fever patients diagnosed in Arizona in 2019, underscoring the economic burden the disease places on the ...
Feb 10, 2021
0
0
